Farhad Amiri

5.0k total citations
45 papers, 4.2k citations indexed

About

Farhad Amiri is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Farhad Amiri has authored 45 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Farhad Amiri's work include Hormonal Regulation and Hypertension (14 papers), Renin-Angiotensin System Studies (13 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). Farhad Amiri is often cited by papers focused on Hormonal Regulation and Hypertension (14 papers), Renin-Angiotensin System Studies (13 papers) and Peroxisome Proliferator-Activated Receptors (12 papers). Farhad Amiri collaborates with scholars based in Canada, United States and Italy. Farhad Amiri's co-authors include Ernesto L. Schiffrin, Rhian M. Touyz, Mário Fritsch Neves, Quy N. Diep, Marc Iglarz, Agostino Virdis, Émilie C. Viel, Dierk Endemann, Karim Benkirane and Pascal Brassard and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Diabetes.

In The Last Decade

Farhad Amiri

45 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhad Amiri Canada 31 1.6k 1.5k 1.3k 1.1k 663 45 4.2k
Gláucia E. Callera Canada 36 1.1k 0.7× 931 0.6× 1.1k 0.9× 1.0k 0.9× 679 1.0× 58 3.5k
Terri J. Allen Australia 48 2.0k 1.3× 1.5k 1.0× 2.0k 1.6× 841 0.7× 724 1.1× 112 6.2k
Anette Fiebeler Germany 33 1.5k 0.9× 1.2k 0.8× 1.3k 1.1× 411 0.4× 840 1.3× 60 4.0k
Shokei Kim Japan 44 2.6k 1.6× 2.6k 1.7× 1.1k 0.9× 915 0.8× 737 1.1× 119 5.9k
Seiji Ueda Japan 39 1.3k 0.8× 949 0.6× 1.1k 0.9× 1.4k 1.3× 561 0.8× 93 4.9k
Livius V. d’Uscio United States 36 1.7k 1.1× 998 0.7× 601 0.5× 2.2k 1.9× 357 0.5× 76 4.0k
Dierk Endemann Germany 21 1.2k 0.7× 782 0.5× 646 0.5× 686 0.6× 388 0.6× 46 2.9k
Hirofumi Hitomi Japan 35 1.2k 0.8× 942 0.6× 1.4k 1.1× 666 0.6× 651 1.0× 98 3.7k
Murielle M. Véniant United States 44 1.0k 0.7× 3.7k 2.4× 1.5k 1.2× 1.2k 1.1× 1.4k 2.1× 95 6.5k
Michael Schupp Germany 34 782 0.5× 2.6k 1.7× 828 0.7× 1.5k 1.3× 481 0.7× 66 4.8k

Countries citing papers authored by Farhad Amiri

Since Specialization
Citations

This map shows the geographic impact of Farhad Amiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Amiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Amiri more than expected).

Fields of papers citing papers by Farhad Amiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Amiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Amiri. The network helps show where Farhad Amiri may publish in the future.

Co-authorship network of co-authors of Farhad Amiri

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Amiri. A scholar is included among the top collaborators of Farhad Amiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Amiri. Farhad Amiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amiri, Farhad, Eun Ae Ko, Danesh Javeshghani, Timothy L. Reudelhuber, & Ernesto L. Schiffrin. (2010). Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice. Journal of Hypertension. 28(6). 1243–1251. 30 indexed citations
2.
Amiri, Farhad, Pierre Paradis, Timothy L. Reudelhuber, & Ernesto L. Schiffrin. (2008). Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells. Journal of Hypertension. 26(6). 1102–1109. 47 indexed citations
3.
Pu, Qian, Pascal Brassard, Danesh Javeshghani, et al.. (2008). Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP. Journal of Hypertension. 26(2). 322–333. 27 indexed citations
4.
Savoia, Carmine, Rhian M. Touyz, Farhad Amiri, & Ernesto L. Schiffrin. (2008). Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients. Hypertension. 51(2). 432–439. 122 indexed citations
5.
Pandey, Nihar R., Karim Benkirane, Farhad Amiri, & Ernesto L. Schiffrin. (2007). Effects of PPAR-γ Knock-down and Hyperglycemia on Insulin Signaling in Vascular Smooth Muscle Cells From Hypertensive Rats. Journal of Cardiovascular Pharmacology. 49(6). 346–354. 12 indexed citations
6.
Montezano, Augusto C., Farhad Amiri, Rita C. Tostes, Rhian M. Touyz, & Ernesto L. Schiffrin. (2007). Inhibitory effects of PPAR-γ on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. Journal of the American Society of Hypertension. 1(2). 150–160. 15 indexed citations
7.
Ciuceis, Carolina De, Farhad Amiri, Marc Iglarz, et al.. (2007). Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II‐induced hypertension in rats. British Journal of Pharmacology. 151(1). 45–53. 29 indexed citations
8.
Ko, Eun Ae, Farhad Amiri, Nihar R. Pandey, et al.. (2006). Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. American Journal of Physiology-Heart and Circulatory Physiology. 292(4). H1789–H1795. 101 indexed citations
9.
Pu, Qian, Farhad Amiri, Philippe O. Gannon, & Ernesto L. Schiffrin. (2005). Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats. Journal of Hypertension. 23(2). 401–409. 33 indexed citations
10.
Neves, Mário Fritsch, Farhad Amiri, Agostino Virdis, Quy N. Diep, & Ernesto L. Schiffrin. (2005). Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Canadian Journal of Physiology and Pharmacology. 83(11). 999–1006. 72 indexed citations
11.
Brassard, Pascal, Farhad Amiri, & Ernesto L. Schiffrin. (2005). Combined Angiotensin II Type 1 and Type 2 Receptor Blockade on Vascular Remodeling and Matrix Metalloproteinases in Resistance Arteries. Hypertension. 46(3). 598–606. 80 indexed citations
12.
Virdis, Agostino, Mário Fritsch Neves, Farhad Amiri, Rhian M. Touyz, & Ernesto L. Schiffrin. (2004). Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. Journal of Hypertension. 22(3). 535–542. 202 indexed citations
13.
Touyz, Rhian M., Guoying Yao, Émilie C. Viel, Farhad Amiri, & Ernesto L. Schiffrin. (2004). Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. Journal of Hypertension. 22(6). 1141–1149. 159 indexed citations
14.
Diep, Quy N., Farhad Amiri, Karim Benkirane, Pierre Paradis, & Ernesto L. Schiffrin. (2004). Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. Canadian Journal of Physiology and Pharmacology. 82(11). 976–985. 41 indexed citations
15.
Neves, Mário Fritsch, Dierk Endemann, Farhad Amiri, et al.. (2004). Small artery mechanics in hyperhomocysteinemic mice. Journal of Hypertension. 22(5). 959–966. 42 indexed citations
16.
Amiri, Farhad, Seán Shaw, Xiaodan Wang, et al.. (2002). Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney International. 61(5). 1605–1616. 116 indexed citations
17.
Amiri, Farhad, et al.. (1999). Renal angiotensin II receptor regulation and reninangiotensin system inhibition in one-kidney, one clip hypertensive rats. Journal of Hypertension. 17(2). 279–286. 11 indexed citations
18.
Amiri, Farhad, Virginia J. Venema, Xiaodan Wang, et al.. (1999). Hyperglycemia Enhances Angiotensin II-induced Janus-activated Kinase/STAT Signaling in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 274(45). 32382–32386. 72 indexed citations
19.
Haddad, Georges E., et al.. (1997). Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Regulatory Peptides. 68(2). 111–117. 13 indexed citations
20.
Amiri, Farhad & Raúl García. (1997). Renal Angiotensin II Receptor Regulation in Two-Kidney, One Clip Hypertensive Rats. Hypertension. 30(3). 337–344. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026